A new study from The University of Texas MD Anderson Cancer Center found that more women will screen for human papillomavirus (HPV) if they can self-test at home. According to...
Cervical cancer screening recommendations for women over age 65 have been lacking empirical evidence; new study found that older women who received a “catch up” screening intervention...
Phase 3 controlled trial showed that self-collection kits and scheduling assistance are key for reaching these populations and preventing cervical cancer.
The World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules...
A randomized controlled trial of 2,275 women in Kenya showed that a single dose of the human papillomavirus (HPV) vaccine was highly effective, according to a news release from...
Scientists presented information at the 2021 AACC Annual Scientific Meeting & Clinical Expo on a new test to measure antibodies in girls who have received a vaccine for human ...
Moffitt Cancer Center researchers demonstrate a link between the presence of cutaneous human papillomavirus and the incidence of squamous cell carcinomas and identify key characteristic...
A study led by Hui-Yi Lin, PhD, Professor of Biostatistics, and a team of researchers at LSU Health New Orleans Schools of Public Health and Medicine has found that adequate levels...
BD (Becton, Dickinson and Company) announced that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for the use of the ThinPrep...